0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial |  ONLINE FIRST
Stephen V. Faraone, PhD; Joseph Biederman, MD
JAMA Psychiatry. Published online May 18, 2016. doi:10.1001/jamapsychiatry.2016.0400

Original Investigation |  ONLINE FIRST
Arthur Caye; Thiago Botter-Maio Rocha, MD, MSc; Luciana Anselmi, PhD; et al.
JAMA Psychiatry. Published online May 18, 2016. doi:10.1001/jamapsychiatry.2016.0383
Includes: Supplemental Content

Original Investigation |  ONLINE FIRST
Jessica C. Agnew-Blais, ScD; Guilherme V. Polanczyk, MD, PhD; Andrea Danese, MD, PhD; et al.
JAMA Psychiatry. Published online May 18, 2016. doi:10.1001/jamapsychiatry.2016.0465
Includes: Supplemental Content

Original Investigation |  ONLINE FIRST
Elina Jokiranta-Olkoniemi, MA; Keely Cheslack-Postava, PhD; Dan Sucksdorff, MD; et al.
JAMA Psychiatry. Published online May 04, 2016. doi:10.1001/jamapsychiatry.2016.0495
Includes: Supplemental Content

Original Investigation | 
Theodore D. Satterthwaite, MD, MA; Daniel H. Wolf, MD, PhD; Monica E. Calkins, PhD; et al.
JAMA Psychiatry. 2016;73(5):515-524. doi:10.1001/jamapsychiatry.2015.3463.
Includes: Supplemental Content

Editorial | 
Philip Shaw, BM, BCh, PhD
JAMA Psychiatry. 2016;73(5):445-446. doi:10.1001/jamapsychiatry.2016.0140.

Original Investigation | 
Daniel Kessler, BS; Michael Angstadt, MAS; Chandra Sripada, MD, PhD
JAMA Psychiatry. 2016;73(5):481-489. doi:10.1001/jamapsychiatry.2016.0088.
Includes: Supplemental Content

Original Investigation |  ONLINE FIRST
Malin Björnsdotter, MSc, PhD; Nancy Wang; Kevin Pelphrey; et al.
JAMA Psychiatry. Published online April 20, 2016. doi:10.1001/jamapsychiatry.2016.0219
Includes: Supplemental Content

Editorial | 
Jeremy Veenstra-VanderWeele, MD; Kelly McGuire, MD, MPA
JAMA Psychiatry. 2016;73(4):327-328. doi:10.1001/jamapsychiatry.2016.0143.

Original Investigation | 
Mark Drakesmith, PhD; Anirban Dutt, MD; Leon Fonville, MSc; et al.
JAMA Psychiatry. 2016;73(4):396-406. doi:10.1001/jamapsychiatry.2015.3375.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Health Agencies Update  | 
Single Question Can Identify Youth at Risk for Alcohol Use Disorder
Julie A. Jacob, MA
JAMA Pediatrics
Viewpoint  | 
Parenting as Primary Prevention
Ellen C. Perrin, MD; Laurel K. Leslie, MD, MPH; Thomas Boat, MD
JAMA
Editorial  | 
Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
Philip Shaw, MD, PhD
JAMA
JAMA Clinical Evidence Synopsis  | 
Methylphenidate for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Ole J. Storebø, PhD; Erik Simonsen, MD, PhD, DrHc; Christian Gluud, MD, DrMedSci